Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy Podcast Por  arte de portada

Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy

Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy

Escúchala gratis

Ver detalles del espectáculo

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

Learn from the experts about selecting the right BTK inhibitor therapy for patients with chronic lymphocytic leukaemia (CLL) in UK clinical practice.

Credit available for this activity expires: 12/16/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-course-cll-clinicians-compass-btk-inhibitor-therapy-2025a1000yei?ecd=bdc_podcast_libsyn_mscpedu

Todavía no hay opiniones